Drug Profile
Research programme: anaemia therapeutic - Cumberland Emerging Technologies
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Cumberland Emerging Technologies; University of Virginia
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Anaemia
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Anaemia in USA
- 30 Sep 2011 Early research in Anaemia in USA (unspecified route)